Elicio Therapeutics ( (ELTX) ) just unveiled an announcement. On August 12, 2025, Elicio Therapeutics announced the publication of follow-up data from its Phase 1 AMPLIFY-201 study in Nature Medicine ...

The Madison Metropolitan School District has entered the next phase of planning and design for its first major capital projects at four local schools.

Developments announced thecompletion of its Phase I drilling campaign to support the conversion of a portion of its current Indicated ...

A new vaccine designed to combat cancer cells in patients with colorectal and pancreatic cancer showed promising results in ...

Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to ...

IO Biotech's phase 3 melanoma trial showed a strong PFS benefit, especially in true 1st-line and PD1-negative patients. Click ...

One thousand dollars invested three years ago is now worth an incredible $10,640 as of Aug. 11. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best ...

Although the official completion deadline for the first phase is 30 months, GMRL aims to finish the work in 20 months.

Kyverna reported $211.7 million in cash, cash equivalents, and marketable securities as of June 30, 2025, which the Company ...

Construction on the first 44 units of senior housing at the former Martel School will begin this fall, Lewiston Housing staff ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

Discover six of the top psychedelic companies developing novel drugs to expand the treatment scope for mental health ...